skip to content
Home

Department of Oncology

 

News Subscribe to News

Read more at: Rebecca Fitzgerald receives OBE for services to cancer

Rebecca Fitzgerald receives OBE for services to cancer

6 March 2023

rebeccaobe_250.png Professor Rebecca Fitzgerald (Department of Oncology and Director of the Early Cancer Institute) has received an Officer of the Order of the British Empire (OBE) for services to cancer for her research in development of new methods of early detection of oesophageal cancer. Rebecca was recognised in the...

Read more at: Daniel Muñoz Espín wins PROSE award

Daniel Muñoz Espín wins PROSE award

6 March 2023

Daniel Muñoz Espín wins PROSE award Congratulations to Daniel Muñoz Espín (Department of Oncology, Early Cancer Institute), whose new book has been awarded a prestigious PROSE award by the Association of American publishers. Since 1976 the PROSE awards have been honouring scholarly works in a number of categories across...

Read more at: Harveer Dev awarded $1 million Challenge grant from the Prostate Cancer Foundation

Harveer Dev awarded $1 million Challenge grant from the Prostate Cancer Foundation

17 February 2023

h-dev.jpg Congratulations to Dr Harveer Dev and colleagues from the University of Cambridge and the Knight Cancer Institute at OHSU who have been awarded a $1 million Challenge grant by the Prostate Cancer Foundation for their project entitled First-In-Man PARP1-selective inhibitor in lethal prostate cancer: mechanisms of...

Read more at: Cambridge Cancer Research Hospital New Milestone

Cambridge Cancer Research Hospital New Milestone

17 February 2023

ccrh_main_entrance.png A full planning application to build a new specialist cancer research hospital for the region on the Cambridge Biomedical Campus has been submitted to Cambridge City Council. The Cambridge Cancer Research Hospital (CCRH) project will change the story of cancer for patients and their families, by...

Read more at: First UK proton beam therapy trial for breast cancer launches

First UK proton beam therapy trial for breast cancer launches

17 February 2023

coles.jpg The PARABLE trial will compare proton beam therapy – which can target radiotherapy beams more precisely – with standard radiotherapy for patients who are at greater risk of long-term heart problems after radiotherapy treatment. It will help to determine whether proton beam therapy can help to deliver adequate...

Read more at: Rebecca Fitzgerald Cancer Research Horizons Award

Rebecca Fitzgerald Cancer Research Horizons Award

17 February 2023

r-fitzgerald.jpg Rebecca Fitzgerald has received the Cancer Research UK (CRUK) Impact Recognition Award. CRUK CEO Michelle Mitchell presented the award to Rebecca and paid tribute to her outstanding and ongoing contribution to oncology, and her determination to drive forward the translation and commercialisation of her...

Read more at: Cambridge Experimental Cancer Medicine Centre funding award

Cambridge Experimental Cancer Medicine Centre funding award

17 February 2023

A team led by Bristi Basu (Department of Oncology, CUH and CRUK Cambridge Centre Pancreatic Cancer Programme Co-lead) and Duncan Jodrell (Department of Oncology and Cambridge Cancer Trials Centre Director) will receive around £3 million over the next five years for Cambridge’s Experimental Cancer Medicine Centre (ECMC)...

Read more at: Breakthrough in understanding how cancer spreads

Breakthrough in understanding how cancer spreads

30 September 2022

gilbertson_richard.jpg Breakthrough in our understanding of how cancer spreads could lead to better treatments. Scientists have discovered that cancer exploits the body’s tissue repair process to spread cells around the body. They found that a protein called NALCN is involved in regulating both tissue repair and metastasis...

Read more at: Launch of First UK Early Cancer Institute

Launch of First UK Early Cancer Institute

30 September 2022

r-fitzgerald.jpg The UK's first physical Early Cancer Institute was officially launched at the University of Cambridge on 21 September 2022. The Early Cancer Institute, based on the Cambridge Biomedical Campus alongside academic, medical and pharmaceutical specialists, aims to help create a world where we can detect cancer...

Read more at: Charlie Massie wins Prostate Cancer UK research award

Charlie Massie wins Prostate Cancer UK research award

30 September 2022

massie.jpg Charlie Massie has been awarded a Prostate Cancer UK research award to investigate the epigenetic evolution of prostate cancer. Epigenetics is the study of how your own behaviours and environment can cause changes that affect the way your genes work, without changing our DNA. Epigenetics has been linked to a...

Contact us

 

Terms and conditions

Accessibility

Sitemap

Study at Cambridge

About the University

Research at Cambridge